NASDAQ:SNES SenesTech (SNES) Stock Forecast, Price & News $1.18 -0.04 (-3.28%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$1.18▼$1.2350-Day Range$1.16▼$1.8152-Week Range$1.02▼$14.60Volume217,118 shsAverage Volume222,117 shsMarket Capitalization$2.42 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media SenesTech MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy2.44% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.81Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.81) to ($3.37) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.41 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for SenesTech. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.44% of the float of SenesTech has been sold short.Short Interest Ratio / Days to CoverSenesTech has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SenesTech has recently increased by 7.38%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSenesTech does not currently pay a dividend.Dividend GrowthSenesTech does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SNES. Previous Next 2.1 News and Social Media Coverage News SentimentSenesTech has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for SenesTech this week, compared to 2 articles on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, SenesTech insiders have not sold or bought any company stock.Percentage Held by Insiders11.90% of the stock of SenesTech is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for SenesTech are expected to grow in the coming year, from ($3.81) to ($3.37) per share.Price to Book Value per Share RatioSenesTech has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About SenesTech (NASDAQ:SNES) StockSenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.Read More Receive SNES Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SenesTech and its competitors with MarketBeat's FREE daily newsletter. Email Address SNES Stock News HeadlinesMay 27, 2023 | americanbankingnews.comSenesTech (NASDAQ:SNES) Lifted to "Sell" at StockNews.comMay 26, 2023 | americanbankingnews.comQ2 2023 Earnings Forecast for SenesTech, Inc. (NASDAQ:SNES) Issued By HC WainwrightMay 31, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Software" to Revolutionize WarfareThis breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>May 15, 2023 | finance.yahoo.comSenesTech to Participate at Lytham Partners Spring 2023 Investor Conference on May 18, 2023May 12, 2023 | finanznachrichten.deSenesTech, Inc.: SenesTech Announces First Quarter 2023 Financial ResultsMay 11, 2023 | finance.yahoo.comSenesTech Announces First Quarter 2023 Financial ResultsMay 10, 2023 | msn.com7SNES : Earnings Preview: SenesTechMay 8, 2023 | finance.yahoo.comContraPest® Deployment Expands to Grain Storage and TransportMay 31, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...May 4, 2023 | finance.yahoo.comSenesTech to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023April 24, 2023 | finance.yahoo.comSenesTech Presents ContraPest® At PEAK 2023 Poultry ShowApril 22, 2023 | americanbankingnews.comAnalysts Issue Forecasts for SenesTech, Inc.'s FY2023 Earnings (NASDAQ:SNES)April 21, 2023 | benzinga.comSenesTech Stock (NASDAQ:SNES), DividendsApril 21, 2023 | americanbankingnews.comSenesTech, Inc. (NASDAQ:SNES) Forecasted to Earn Q1 2023 Earnings of ($0.36) Per ShareApril 19, 2023 | americanbankingnews.comSenesTech (NASDAQ:SNES) Earns "Buy" Rating from HC WainwrightApril 18, 2023 | markets.businessinsider.comSenesTech (SNES) Receives a Rating Update from a Top AnalystApril 17, 2023 | finance.yahoo.comSenesTech Presents ContraPest® At New York's Rodent RoundupApril 12, 2023 | finance.yahoo.comSenesTech Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesApril 11, 2023 | finance.yahoo.comSenesTech and ContraPest® Featured at the Animal Care Expo in New OrleansApril 10, 2023 | finance.yahoo.comSenesTech Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesApril 10, 2023 | finance.yahoo.comLos Angeles County Specifies Fertility Control (ContraPest®) in More Requests For ProposalApril 5, 2023 | finance.yahoo.comSenesTech Signs a Distribution Agreement with Target Specialty Products for ContraPest®March 30, 2023 | americanbankingnews.comSenesTech (NASDAQ:SNES) Receives New Coverage from Analysts at StockNews.comMarch 29, 2023 | finance.yahoo.comTIME Magazine Takes a Closer Look at ContraPest as a Solution to Global Rat InfestationsMarch 22, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on SenesTech (NASDAQ:SNES)March 20, 2023 | finance.yahoo.comSenesTech, Inc. (NASDAQ:SNES) Q4 2022 Earnings Call TranscriptMarch 16, 2023 | finance.yahoo.comSenesTech Announces 2022 Financial ResultsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SNES Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SenesTech and its competitors with MarketBeat's FREE daily newsletter. Email Address SNES Company Calendar Last Earnings5/11/2023Today5/31/2023Next Earnings (Estimated)8/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Agricultural chemicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SNES CUSIPN/A CIK1680378 Webwww.senestech.com Phone(928) 779-4143FaxN/AEmployees26Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,690,000.00 Net Margins-889.31% Pretax Margin-889.31% Return on Equity-216.13% Return on Assets-159.22% Debt Debt-to-Equity RatioN/A Current Ratio4.00 Quick Ratio3.19 Sales & Book Value Annual Sales$1.02 million Price / Sales2.41 Cash FlowN/A Price / Cash FlowN/A Book Value$1.70 per share Price / Book0.71Miscellaneous Outstanding Shares2,050,000Free Float1,809,000Market Cap$2.46 million OptionableNot Optionable Beta1.08 Key ExecutivesJoel L. FruendtPresident, Chief Executive Officer & DirectorThomas C. ChestermanCFO, Secretary, Treasurer & Executive VPDan PalaskyChief Technical OfficerAlice MytonVice President & Corporate ControllerCharmonte WatkinsDirector-Regulatory AffairsKey CompetitorsGRI BioNASDAQ:GRIThermoGenesisNASDAQ:THMOAkandaNASDAQ:AKANBIOLASENASDAQ:BIOLPolarityTENASDAQ:PTEView All Competitors SNES Stock - Frequently Asked Questions Should I buy or sell SenesTech stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SenesTech in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SNES shares. View SNES analyst ratings or view top-rated stocks. How have SNES shares performed in 2023? SenesTech's stock was trading at $3.09 at the start of the year. Since then, SNES stock has decreased by 61.2% and is now trading at $1.20. View the best growth stocks for 2023 here. When is SenesTech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023. View our SNES earnings forecast. How were SenesTech's earnings last quarter? SenesTech, Inc. (NASDAQ:SNES) released its earnings results on Thursday, May, 11th. The company reported ($1.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.81) by $0.51. The business earned $0.23 million during the quarter, compared to analysts' expectations of $0.32 million. SenesTech had a negative trailing twelve-month return on equity of 216.13% and a negative net margin of 889.31%. When did SenesTech's stock split? SenesTech shares split on the morning of Thursday, September 1st 2022. The 2-1 split was announced on Thursday, September 1st 2022. The newly issued shares were distributed to shareholders after the market closes on Thursday, September 1st 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What other stocks do shareholders of SenesTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include Carrizo Oil & Gas (CRZO), Auris Medical (EARS), Marathon Oil (MRO), Adamis Pharmaceuticals (ADMP), McDermott International (MDR), ZIOPHARM Oncology (ZIOP), Citius Pharmaceuticals (CTXR) and DURECT (DRRX). When did SenesTech IPO? (SNES) raised $15 million in an IPO on Thursday, December 8th 2016. The company issued 1,900,000 shares at $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager. What is SenesTech's stock symbol? SenesTech trades on the NASDAQ under the ticker symbol "SNES." How do I buy shares of SenesTech? Shares of SNES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is SenesTech's stock price today? One share of SNES stock can currently be purchased for approximately $1.20. How much money does SenesTech make? SenesTech (NASDAQ:SNES) has a market capitalization of $2.46 million and generates $1.02 million in revenue each year. How can I contact SenesTech? SenesTech's mailing address is 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027. The official website for the company is www.senestech.com. The company can be reached via phone at (928) 779-4143 or via email at senestech@lythampartners.com. This page (NASDAQ:SNES) was last updated on 5/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SenesTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.